- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Serum Immunoglobulins and complement subfactors levels in sodium valproate treated epileptic patients | ||
| Iraqi Journal of Pharmacy | ||
| Article 1, Volume 11, Issue 1, 2011, Pages 1-5 PDF (0 K) | ||
| DOI: 10.33899/iphr.2011.49568 | ||
| Authors | ||
| Nazar A-K Hami; Mohammed Khalid Al-Nori; Omer AH Ahmed; Imad Abdul-Jabbar Thanoon | ||
| Abstract | ||
| Objectives: To assess, the serum levels of immunoglobulins (IgG, IgA, IgM) and complement subfactors (C٣, C٤) in newly diagnosed epileptic patients in the pretherapy stage and ٣ months after valproate therapy, in comparison with controls. Methods: This study was conducted at Iben-Seena Hospital and the College of Medicine- University of Mosul from January to December ٢٠٠٩. Forty-two newly diagnosed epileptic patients were selected and included in this study. Fifty apparently healthy subjects , age and sex matched to the patients group also included and taken as a control. Initially from both the patients and controls, blood samples were taken and assessment of sera levels of immunoglobulins and complement subfactors were done by single radial immuno diffusion method, using commercial kits. Then patients were put on valporate therapy for ٣ months and a blood sample were taken from the patients and assay of the same parameters mentioned above were done using the same technique and the same kits. Results: There were insignificant differences between patients in pre-therapy stage and controls with regard serum immunoglobulin levels (and complement subfactors). Also there were insignificant differences between epileptic patients before and ٣ months after therapy with valproate . Conclusion: valproate as an anticonvulsant have no influence on serum immunoglobulin (IgG, IgA, IgM) and complement subfactors (C٣, C٤) after ٣ months of therapy. | ||
| Keywords | ||
| newly diagnosed epileptic; valproate therapy; immunoglobulin and complements subfactors levels | ||
|
Statistics Article View: 503 PDF Download: 298 |
||